Dr. Philip Arlen to Speak at 16th Annual Drug Discovery Summit
Dr. Philip Arlen will be speaking at this years Drug Discovery Summit June 8-9th in...
02Jun
20May
Precision Biologics Completes Patient Accrual to its Ensituximab Phase 2 Colorectal Cancer Study
FOR IMMEDIATE RELEASE….Rockville, MD, May 20, 2015 Precision Biologics is pleased to announce the completion of...
18May
Yale Cancer Center and the Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill Joins Precision Biologics as Collaborators
Precision Biologics is pleased to announce the addition of both Yale Cancer Center at the...
12May
Notice of Annual Meeting of Stockholders To Be Held on June 12, 2015
PRECISION BIOLOGICS, INC. NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 12, 2015 at 6:00...
03Feb
PRNewswire: EMD Millipore Announces Agreement with Precision Biologics, Inc. to Provide Upstream Process Development Services
DARMSTADT, Germany, Feb. 2, 2015 /PRNewswire/ -- EMD Millipore, the Life Science business of Merck KGaA of Darmstadt, today announced an...
12Jan
NPC-1C Therapy Provides Hope for patients with metastatic Colorectal Cancer Showing Exciting Preliminary Results
Precision Biologics is pleased to announce promising overall survival (OS) data from its ongoing Phase...